The Safety and Efficacy of the Buprenorphine Transdermal Delivery System in Subjects With Osteoarthritis Pain.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1996
The objective of this study is to demonstrate the effectiveness and tolerability of the buprenorphine transdermal system (5, 10, and 20 mg) in comparison to placebo transdermal system and immediate release oxycodone/acetaminophen in subjects with osteoarthritis pain inadequately treated with non-opioid analgesics. The double-blind treatment intervention duration is 60 days.
Epistemonikos ID: e2e44db2e7c35b77d2ded30ad8453fbbfd5b7ad5
First added on: May 04, 2024